Australian biotech giant CSL plans to lay off 3,000 people, causing its stock price to drop by 15%.

Australian biotechnology giant CSL announced on Tuesday that it will spin off its vaccine division and lay off about 3,000 employees, equivalent to 15% of its workforce. CSL's stock price fell 15% in the afternoon and could potentially set a record for the largest single-day drop in history.